Content area
Full text
The FDA gave its Office of Medical Policy a long-awaited org chart upgrade, making it a "super office" and giving the Division of Drug Marketing, Advertising and Communication, or DDMAC, a new acronym: OPDP.
The DDMAC becomes the Office of Prescription Drug Promotion, a level-up that will mean more authority and...





